Compare DG & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DG | MDLN |
|---|---|---|
| Founded | 1939 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.5B | 30.7B |
| IPO Year | 2008 | 2025 |
| Metric | DG | MDLN |
|---|---|---|
| Price | $133.73 | $39.62 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 31 | 27 |
| Target Price | ★ $141.52 | $44.31 |
| AVG Volume (30 Days) | 1.9M | ★ 9.6M |
| Earning Date | 12-03-2026 | 11-04-2026 |
| Dividend Yield | ★ 1.71% | N/A |
| EPS Growth | ★ 34.05 | N/A |
| EPS | ★ 4.49 | 0.45 |
| Revenue | ★ $42,724,369,000.00 | $28,432,000,000.00 |
| Revenue This Year | $4.27 | $9.83 |
| Revenue Next Year | $4.05 | $7.84 |
| P/E Ratio | ★ $31.55 | $89.67 |
| Revenue Growth | 5.20 | ★ 11.47 |
| 52 Week Low | $97.32 | $31.37 |
| 52 Week High | $158.23 | $50.88 |
| Indicator | DG | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 53.09 | 70.09 |
| Support Level | $115.67 | $35.41 |
| Resistance Level | $136.62 | $43.31 |
| Average True Range (ATR) | 5.23 | 1.50 |
| MACD | 0.33 | 0.70 |
| Stochastic Oscillator | 44.70 | 81.62 |
Since its beginning in 1939, Dollar General has grown to become the largest dollar store operator in the United States, with more than 20,000 small-box discount stores across 48 states. The firm generated over $42 billion in fiscal 2025 sales. The retailer maintains a heavy concentration of stores in rural and low-income markets underserved by big-box retailers. It's 11,000 stock-keeping units, including 2,000 priced at $1 or less, span consumables (82% of sales), seasonal items (10%), home products (5%), and apparel (3%). More than 20% of sales are derived from private label.
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.